ZYDUS LIFESCIENCES STOCK UPDATE

Zydus Life's US business is going to report a good set of numbers. Also, in India, wellness products are doing good, Overall Zydus Life will tend to report some 25% EBITDA margin. Therefore, Sharekhan By BNP Paribas has a buy call on Zydus Life with...

Based on average market capitalization from January to June 2024, seven stocks are poised to join the large-cap category. The list includes two-wheeler giant Hero MotoCorp, state-run companies BHEL and NHPC, along with Zydus Lifesciences, JSW Energy...

Indicating that the company is still interested in the mega Tajpur deep sea port in West Bengal, JSW Infrastructure Ltd said that it remains open to re-evaluate its strategy for the project.

Quant Mutual Fund is under Sebi inquiry for suspected front-running, leading to search and seizure operations in Mumbai and Hyderabad.

I​n Tuesday's trading session, five stocks saw increased open interest and trading volumes despite falling prices, indicating a short buildup as investors anticipate further declines, prompting fresh short positions in the Futures and Options segmen...

Steady costs and firm domestic demand supported corporate performance in the March quarter.

Existing largecaps likeICICI Prudential Life Insurance Company, ICICI Lombard General Insurance Company, Polycab India, SRF, Marico, SBI Cards & Payment Services and Berger Paints are likely to lose their tags.

Top mutual funds like SBI Mutual Fund, Axis MF, Nippon India MF bought 19 midcap stocks, including Suzlon Energy, NHPC, and PB Fintech, the parent of online insurance aggregator Policybazaar.

Parag Parikh Flexi Cap Fund increases stake in ITC, HDFC, and Kotak while making exits from Bajaj Finance and HUL in May. The largest flexi cap fund manages assets worth Rs 66,383 crore and is benchmarked against Nifty 500- TRI.

Zydus Lifesciences Ltd., incorporated in the year 1995, is a Large Cap company (having a market cap of Rs 105126.30 Crore) operating in Pharmaceuticals sector.

​So, now 31% margin for Divi’s is a good thing as against the lower margin what it used to clock. And going forward, this kind of margins are sustainable because custom synthesis business is doing good and they also have good order pipeline.

​In Saturday's trading session, five stocks experienced a buildup of fresh long positions, denoting a bullish trend.

Zydus Lifesciences on Friday reported Rs 1,182 crore net profit in Q4FY24, a threefold year-on-year (YoY) jump led by growth in US, India, Europe and emerging market sales.

In the upcoming Amfi Semi-Annual Categorisation for the second half of 2024, seven stocks, including Hero MotoCorp and BHEL, are poised to move to the large-cap category from mid-cap. Stellar rallies have propelled their returns over the past year.

The likely move comes on the back of a strong rally over the last one year. BHEL, JSW and NHPC have delivered multibagger returns of 239%, 135% and 110%, respectively. Zydus, Hero Moto, Samvardhana and Bosh have yielded between 85 and 48% returns du...